Rare diseases
Investigational molecules
Locations
A study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
PolandA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
PolandPolandA study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer
PolandA study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer
PolandA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
PolandA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
PolandA study of MK-1084 and a drug combination for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations.
PolandA study of donidalorsen for children with hereditary angioedema
PolandA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
PolandA study to evaluate the efficacy and safety of etrasimod arginine in children with moderately to severely active ulcerative colitis
PolandA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
